Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

LIPO Lipella Pharmaceuticals Inc

2,66

-0,05 (-1,85%)

Nach Börsenschluss

Zuletzt aktualisiert: 01:08:41

Verzögert um 15 Minuten

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Lipella Pharmaceuticals (NASDAQ:LIPO)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Lipella Pharmaceuticals Charts.

Lipella Pharmaceuticals (NASDAQ:LIPO)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Lipella Pharmaceuticals Charts.

News Lipella Pharmaceuticals Inc

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Donnerstag 30 Januar 2025 (2 Stunden vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 18 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Donnerstag 16 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 13 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.’s $875,500 Private Placement
Freitag 10 Januar 2025 (3 Wochen vor) • GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933
Dienstag 7 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 6 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Samstag 4 Januar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 4 Januar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 30 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Samstag 28 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 28 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Weitere Lipella Pharmaceuticals Inc News-Artikel

Deutsche Lufthansa

BNP Paribas (QX)

Energy Select Sector SPDR

Health Care Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen